Cardiff Lexington Corp (CDIX) fair value: what the stock is really worth
As of Nov 18, 2026: fair value (intrinsic value) of Cardiff Lexington Corp stock $0.00, price $0.01, that is 65.4% below the price, quality 23 out of 100. Rating: strongly overvalued. Calculated from audited financials with 2 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Cardiff Lexington Corp
CDIX · USFar too expensive (fair value 65% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.
How to read this chart
60‑month range $0.0050 – $2,003 · fair‑value band $0.0043 – $0.0046 · the $0.0130 price screens above the $0.0045 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.
Every Wednesday you see whether Cardiff Lexington is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Cardiff Lexington Corporation, through its subsidiaries, provides orthopedics, spine care, and pain management services in the United States. The company operates through two segments, Healthcare and Real Estate.
Show moreShow less
The company provides diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. It also engages in real estate business.
The company also offers orthopedic and pain procedure services, including hip and knee replacement, shoulder reconstruction, fracture care, and hand surgery, as well as spinal surgery.
It serves personal injury attorneys, insurance carriers, physical therapy providers, and chiropractic care providers. The company was formerly known as Cardiff International, Inc. and changed its name to Cardiff Lexington Corporation in January 2018.
Cardiff Lexington Corporation is based in Lexington, Kentucky.
Stock analysis
Cardiff Lexington Corp (CDIX) currently trades at $0.0130, while our model-based Fair Value estimate is $0.0045, 65% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 2 models at a data quality of 83/100, which puts the data coverage at low.
Scenario range: $0.0043 (bear) to $0.0046 (bull), the price of $0.0130 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 23/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Cardiff Lexington Corp reported revenue of $11.5M in FY2025 versus $10.0M in FY2021, a compound +3.6%/yr. Reported net income was −$6.5M in FY2025.
Key figures
Market cap $198K Micro · EPS (TTM) $−1.00 · Net margin −92.1% · Return on equity −202% · Return on assets (EBIT) 14.4% (5-year average) · Operating margin −25.2% · Revenue (TTM) $10.2M · Revenue growth (YoY) −22.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (medium confidence).
What moves the price
The share trades about 100% below its 52-week high and 160% above its 52-week low.
For context, the median of 10 Healthcare peers we cover trades at 3% fair-value upside, at −65%, CDIX screens richer than that median.
Fair Value models
All 2 models by family
The fair value above starts from this blend and is adjusted for dilution from new shares.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Insider trades
In the last 6 months, no officer or director bought or sold shares on the open market.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Source: SEC Form 4, as of Nov 18, 2026. All filings at the SEC ↗
Revenue & earnings trend
CDIX screens overvalued: fair value 65% below the price. Compare with HCA Healthcare, Inc →
Compare Cardiff Lexington Corp with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 250 stocks
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
Context: sector, industry, market
- Is the Financials sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- EBIT margin by industry
- P/S ratio by industry
- Stock screener with 62 metrics
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Fresenius Medical Care AG FMS | $20.95 | $45.53 | +117% | vs CDIX |
| DaVita Inc DVA | $161.79 | $218.90 | +35% | vs CDIX |
| Aier Eye Hospital Group 300015 | ¥9.02 | ¥10.88 | +21% | vs CDIX |
| HCA Healthcare, Inc HCA | $476.35 | $547.34 | +15% | vs CDIX |
| Tenet Healthcare Corporation THC | $271.34 | $279.20 | +3% | vs CDIX |
| The Ensign Group ENSG | $182.98 | $140.09 | −23% | vs CDIX |
| Encompass Health Corporation EHC | $134.93 | $94.81 | −30% | vs CDIX |
| Fresenius SE FRE | €51.78 | €34.77 | −33% | vs CDIX |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 207.90 SAR | 109.45 SAR | −47% | vs CDIX |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,738 | ₹2,908 | −67% | vs CDIX |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Cardiff Lexington Corp (CDIX) overvalued or undervalued?
What is the fair value of CDIX?
What is the quality score of CDIX?
What is the price target for Cardiff Lexington Corp (CDIX)?
What is the Cardiff Lexington Corp stock forecast for 2026?
What is the revenue of Cardiff Lexington Corp (CDIX)?
What is the intrinsic value of Cardiff Lexington Corp (CDIX)?
Is Cardiff Lexington Corp stock overvalued or undervalued in 2026?
Is fair value the same as the market price of CDIX?
How much is Cardiff Lexington Corp worth?
What do the bullish and bearish scenarios say about CDIX?
How solid is the balance sheet of Cardiff Lexington Corp (CDIX)?
How far is CDIX from its 52-week high?
Which stocks are comparable to Cardiff Lexington Corp?
Is Cardiff Lexington Corp stock attractive at the current price?
How is the fair value of CDIX calculated?
Is it still worth investing in stocks now?
What is the share price of Cardiff Lexington Corp (CDIX)?
What should I pay attention to with Cardiff Lexington Corp right now?
Key figures of Cardiff Lexington Corp
How large is the market capitalisation of Cardiff Lexington Corp (CDIX)?
What are the earnings per share of Cardiff Lexington Corp (CDIX)?
What is the net margin of Cardiff Lexington Corp (CDIX)?
What is the return on equity of Cardiff Lexington Corp (CDIX)?
What is the EBIT return on assets of Cardiff Lexington Corp (CDIX)?
What is the operating margin of Cardiff Lexington Corp (CDIX)?
How fast is revenue growing at Cardiff Lexington Corp (CDIX)?
How fast are earnings growing at Cardiff Lexington Corp (CDIX)?
How much free cash flow does Cardiff Lexington Corp (CDIX) generate?
How much net debt does Cardiff Lexington Corp (CDIX) carry?
Watch Cardiff Lexington Corp in the live analysis
One click puts Cardiff Lexington Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.